Bone Marrow Adiposity, Bone Mineral Density and Wnt/β-catenin Pathway Inhibitors Levels in Hemodialysis Patients

Overview

Journal J Bone Metab

Date 2022 Jun 20

PMID 35718928

Authors

Yue-Pei Wang

Nada Khelifi

Cyrille De Halleux

Roth-Visal Ung

France Samson

Claudia Gagnon

Fabrice Mac-Way

Affiliations

Soon will be listed here.

Abstract

Background: Marrow adipose tissue (MAT) is known to accumulate in patients with chronic kidney disease. This pilot study aimed to evaluate bone mineral density (BMD), MAT, visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) using computed tomography (CT) scans and to explore correlations between bone parameters, circulating Wnt/β-catenin pathway inhibitor levels, and adipose tissue parameters.

Methods: Single-center cross-sectional pilot study conducted in hemodialysis patients at the Centre Universitaire de Québec, Hôtel-Dieu de Québec hospital, Canada. CT-scan slices were acquired at the levels of the hip, L3 vertebra, and tibia. Volumetric and areal BMD, tibia cortical thickness, VAT and SAT area, and fat marrow index (FMI) were analyzed using the Mindways QCT Pro software. Blood levels of sclerostin, dickkopf-related protein 1 (DKK1), fibroblast growth factor 23, and α-Klotho were assessed. Spearman's rho test was used to evaluate correlations.

Results: Fifteen hemodialysis patients (median age, 75 [66-82] years; 80% male; dialysis vintage, 39.3 [27.4-71.0] months) were included. While inverse correlations were obtained between L3 FMI and BMD, positive correlations were found between proximal tibial FMI and vertebral and tibial BMD, as well as with tibial (proximal and distal) cortical thickness. VAT had a positive correlation with α-Klotho levels, whereas L3 FMI had a negative correlation with DKK1 levels.

Conclusions: CT-scan allows simultaneous evaluation of bone and marrow adiposity in dialysis patients. Correlations between MAT and BMD vary depending on the bone site evaluated. DKK1 and α-Klotho levels correlate with adipose tissue accumulation in dialysis patients.

Citing Articles

Association of serum sclerostin levels with marrow adiposity in postmenopausal women with glucocorticoid-induced osteoporosis.

Li W, Wang W, Zhang M, Chen Q, Li F, Li S BMC Endocr Disord. 2024; 24(1):55.

PMID: 38679740 PMC: 11056049. DOI: 10.1186/s12902-024-01591-8.

Relationship between bone marrow adipose tissue and kidney function in postmenopausal women.

Badr S, Cotten A, Mentaverri R, Lombardo D, Labreuche J, Martin C Bone Rep. 2023; 19:101713.

PMID: 37711545 PMC: 10498167. DOI: 10.1016/j.bonr.2023.101713.

Relationships between Circulating Sclerostin, Bone Marrow Adiposity, Other Adipose Deposits and Lean Mass in Post-Menopausal Women.

Courtalin M, Bertheaume N, Badr S, During A, Lombardo D, Deken V Int J Mol Sci. 2023; 24(6).

PMID: 36982995 PMC: 10053867. DOI: 10.3390/ijms24065922.

References

Moorthi R, Fadel W, Eckert G, Ponsler-Sipes K, Moe S, Lin C . Bone marrow fat is increased in chronic kidney disease by magnetic resonance spectroscopy. Osteoporos Int. 2015; 26(6):1801-7. PMC: 4582653. DOI: 10.1007/s00198-015-3064-7. View

Singhal V, Maffazioli G, Cano Sokoloff N, Ackerman K, Lee H, Gupta N . Regional fat depots and their relationship to bone density and microarchitecture in young oligo-amenorrheic athletes. Bone. 2015; 77:83-90. PMC: 4447547. DOI: 10.1016/j.bone.2015.04.005. View

Desbiens L, Sidibe A, Ung R, Fortier C, Munger M, Wang Y . FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study. Osteoporos Int. 2018; 29(10):2345-2353. DOI: 10.1007/s00198-018-4598-2. View

Zhang J, Wang N . Leptin in chronic kidney disease: a link between hematopoiesis, bone metabolism, and nutrition. Int Urol Nephrol. 2013; 46(6):1169-74. DOI: 10.1007/s11255-013-0623-8. View

Nuttall M, Patton A, Olivera D, Nadeau D, Gowen M . Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J Bone Miner Res. 1998; 13(3):371-82. DOI: 10.1359/jbmr.1998.13.3.371. View

Justesen J, Stenderup K, Ebbesen E, Mosekilde L, Steiniche T, Kassem M . Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology. 2001; 2(3):165-71. DOI: 10.1023/a:1011513223894. View

Cann C, Adams J, Brown J, Brett A . CTXA hip--an extension of classical DXA measurements using quantitative CT. PLoS One. 2014; 9(3):e91904. PMC: 3956816. DOI: 10.1371/journal.pone.0091904. View

Li X, Kuo D, Schafer A, Porzig A, Link T, Black D . Quantification of vertebral bone marrow fat content using 3 Tesla MR spectroscopy: reproducibility, vertebral variation, and applications in osteoporosis. J Magn Reson Imaging. 2011; 33(4):974-9. PMC: 3072841. DOI: 10.1002/jmri.22489. View

Foley R, Parfrey P, Sarnak M . Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32(5 Suppl 3):S112-9. DOI: 10.1053/ajkd.1998.v32.pm9820470. View

10.

Kremer R, Gilsanz V . Fat and Bone: An Odd Couple. Front Endocrinol (Lausanne). 2016; 6:190. PMC: 4779997. DOI: 10.3389/fendo.2015.00190. View

11.

Kugel H, Jung C, Schulte O, Heindel W . Age- and sex-specific differences in the 1H-spectrum of vertebral bone marrow. J Magn Reson Imaging. 2001; 13(2):263-8. DOI: 10.1002/1522-2586(200102)13:2<263::aid-jmri1038>3.0.co;2-m. View

12.

Schunk S, Floege J, Fliser D, Speer T . WNT-β-catenin signalling - a versatile player in kidney injury and repair. Nat Rev Nephrol. 2020; 17(3):172-184. DOI: 10.1038/s41581-020-00343-w. View

13.

Shen W, Scherzer R, Gantz M, Chen J, Punyanitya M, Lewis C . Relationship between MRI-measured bone marrow adipose tissue and hip and spine bone mineral density in African-American and Caucasian participants: the CARDIA study. J Clin Endocrinol Metab. 2012; 97(4):1337-46. PMC: 3319176. DOI: 10.1210/jc.2011-2605. View

14.

Ikeda T, Sakurai K . [Influence of bone marrow fat on the determination of bone mineral content by QCT]. Nihon Igaku Hoshasen Gakkai Zasshi. 1994; 54(9):886-96. View

15.

Sui B, Hu C, Liao L, Chen Y, Zhang X, Fu X . Mesenchymal progenitors in osteopenias of diverse pathologies: differential characteristics in the common shift from osteoblastogenesis to adipogenesis. Sci Rep. 2016; 6:30186. PMC: 4957106. DOI: 10.1038/srep30186. View

16.

Kiel D, Kauppila L, Cupples L, Hannan M, ODonnell C, Wilson P . Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif Tissue Int. 2001; 68(5):271-6. DOI: 10.1007/BF02390833. View

17.

Bisson S, Ung R, Mac-Way F . Role of the Wnt/-Catenin Pathway in Renal Osteodystrophy. Int J Endocrinol. 2018; 2018:5893514. PMC: 5901476. DOI: 10.1155/2018/5893514. View

18.

Katergari S, Passadakis P, Milousis A, Passadaki T, Asimakopoulos B, Mantatzis M . Subcutaneous and total fat at L4-L5 and subcutaneous, visceral and total fat at L3-L4 are important contributors of fasting and postprandial adiponectin levels. Endocr Res. 2015; 40(3):127-32. DOI: 10.3109/07435800.2014.920349. View

19.

Fairfield H, Rosen C, Reagan M . Connecting Bone and Fat: The Potential Role for Sclerostin. Curr Mol Biol Rep. 2017; 3(2):114-121. PMC: 5448707. DOI: 10.1007/s40610-017-0057-7. View

20.

Wong A, Chandrakumar A, Whyte R, Reitsma S, Gillick H, Pokhoy A . Bone Marrow and Muscle Fat Infiltration Are Correlated among Postmenopausal Women With Osteoporosis: The AMBERS Cohort Study. J Bone Miner Res. 2019; 35(3):516-527. DOI: 10.1002/jbmr.3910. View